Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2009

01-02-2009 | Review

Psoriatic arthritis: from pathogenesis to therapy

Authors: Oliver FitzGerald, Robert Winchester

Published in: Arthritis Research & Therapy | Issue 1/2009

Login to get access

Abstract

Psoriatic arthritis is a multigenic autoimmune disease that involves synovial tissue, entheseal sites and skin, and that may result in significant joint damage. Although there are no diagnostic tests for psoriatic arthritis, research has identified consistent features that help to distinguish the condition from other common rheumatic diseases. Comparison of HLA-B and HLA-C regions in psoriatic arthritis with those in psoriasis without joint involvement demonstrates significant differences, such that psoriatic arthritis cannot be viewed simply as a subset of genetically homogeneous psoriasis. T-cell receptor phenotypic studies have failed to identify antigen-driven clones, and an alternative hypothesis for CD8 stimulation involving innate immune signals is proposed. Finally, imaging studies have highlighted entheseal involvement in psoriatic arthritis, and it is possible that entheseal-derived antigens may trigger an immune response that is critically involved in disease pathogenesis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Costello P, Bresnihan B, O'Farrelly C, FitzGerald O: Predominance of CD8+ T lymphocytes in psoriatic arthritis. J Rheumatol. 1999, 26: 1117-1124.PubMed Costello P, Bresnihan B, O'Farrelly C, FitzGerald O: Predominance of CD8+ T lymphocytes in psoriatic arthritis. J Rheumatol. 1999, 26: 1117-1124.PubMed
2.
go back to reference Snowden JA, Heaton DC: Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. Br J Dermatol. 1997, 137: 130-132. 10.1111/j.1365-2133.1997.tb03715.x.CrossRefPubMed Snowden JA, Heaton DC: Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. Br J Dermatol. 1997, 137: 130-132. 10.1111/j.1365-2133.1997.tb03715.x.CrossRefPubMed
3.
go back to reference Winchester R, Minevich G, Kane D, Bresnihan B, Greenberg D, FitzGerald O: Heterogeneity of the psoriasis phenotype revealed by HLA class I haplotype associations in psoriatic arthritis and psoriasis. Clin Immunol. 2008, 127 (Suppl 1): S88-S89. 10.1016/j.clim.2008.03.247.CrossRef Winchester R, Minevich G, Kane D, Bresnihan B, Greenberg D, FitzGerald O: Heterogeneity of the psoriasis phenotype revealed by HLA class I haplotype associations in psoriatic arthritis and psoriasis. Clin Immunol. 2008, 127 (Suppl 1): S88-S89. 10.1016/j.clim.2008.03.247.CrossRef
4.
go back to reference Winchester R: Genetics of psoriasis and psoriatic arthritis. Psoriatic and Reactive Arthritis – A Companion to Rheumatology. Edited by: Ritchlin CT, FitzGerald O. 2007, Amsterdam, The Netherlands: Elsevier Winchester R: Genetics of psoriasis and psoriatic arthritis. Psoriatic and Reactive Arthritis – A Companion to Rheumatology. Edited by: Ritchlin CT, FitzGerald O. 2007, Amsterdam, The Netherlands: Elsevier
5.
go back to reference Ho PY, Barton A, Worthington J, Plant D, Griffiths CE, Young HS, Bradburn P, Thomson W, Silman AJ, Bruce IN: Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis. 2008, 67: 677-682. 10.1136/ard.2007.071399.PubMedCentralCrossRefPubMed Ho PY, Barton A, Worthington J, Plant D, Griffiths CE, Young HS, Bradburn P, Thomson W, Silman AJ, Bruce IN: Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis. 2008, 67: 677-682. 10.1136/ard.2007.071399.PubMedCentralCrossRefPubMed
6.
go back to reference Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD: Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell. 1990, 63: 1099-1112. 10.1016/0092-8674(90)90512-D.CrossRefPubMed Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD: Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell. 1990, 63: 1099-1112. 10.1016/0092-8674(90)90512-D.CrossRefPubMed
7.
go back to reference Costello PJ, Winchester RJ, Curran SA, Peterson KS, Kane DJ, Bresnihan B, FitzGerald OM: Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions that appear antigen driven. J Immunol. 2001, 166: 2878-2886.CrossRefPubMed Costello PJ, Winchester RJ, Curran SA, Peterson KS, Kane DJ, Bresnihan B, FitzGerald OM: Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions that appear antigen driven. J Immunol. 2001, 166: 2878-2886.CrossRefPubMed
8.
go back to reference Curran SA, Fitzgerald OM, Costello PJ, Selby JM, Kane DJ, Bresnihan B, Winchester R: Nucleotide sequencing of psoriatic arthritis tissue before and during methotrexate administration reveals a complex inflammatory T cell infiltrate with very few clones exhibiting features that suggest they drive the inflammatory process by recognizing autoantigens. J Immunol. 2004, 172: 1935-1944.CrossRefPubMed Curran SA, Fitzgerald OM, Costello PJ, Selby JM, Kane DJ, Bresnihan B, Winchester R: Nucleotide sequencing of psoriatic arthritis tissue before and during methotrexate administration reveals a complex inflammatory T cell infiltrate with very few clones exhibiting features that suggest they drive the inflammatory process by recognizing autoantigens. J Immunol. 2004, 172: 1935-1944.CrossRefPubMed
9.
go back to reference Turner SJ, Doherty PC, McCluskey J, Rossjohn J: Structural determinants of T-cell receptor bias in immunity. Nat Rev. 2006, 6: 883-894. Turner SJ, Doherty PC, McCluskey J, Rossjohn J: Structural determinants of T-cell receptor bias in immunity. Nat Rev. 2006, 6: 883-894.
10.
go back to reference Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M: Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol. 2004, 173: 4273-4276.CrossRefPubMed Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M: Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol. 2004, 173: 4273-4276.CrossRefPubMed
11.
go back to reference Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN: Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis. 2008, 67: 672-676. 10.1136/ard.2007.073932.CrossRefPubMed Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN: Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis. 2008, 67: 672-676. 10.1136/ard.2007.073932.CrossRefPubMed
12.
go back to reference Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, Fitzgerald O: Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum. 1993, 36: 893-900. 10.1002/art.1780360705.CrossRefPubMed Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, Fitzgerald O: Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum. 1993, 36: 893-900. 10.1002/art.1780360705.CrossRefPubMed
13.
go back to reference Kruithof E, Baeten D, De Rycke L, Vandooren B, Foell D, Roth J, Canete JD, Boots AM, Veys EM, De Keyser F: Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther. 2005, 7: R569-R580. 10.1186/ar1698.PubMedCentralCrossRefPubMed Kruithof E, Baeten D, De Rycke L, Vandooren B, Foell D, Roth J, Canete JD, Boots AM, Veys EM, De Keyser F: Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther. 2005, 7: R569-R580. 10.1186/ar1698.PubMedCentralCrossRefPubMed
14.
go back to reference Danning CL, Illei GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB: Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum. 2000, 43: 1244-1256. 10.1002/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2.CrossRefPubMed Danning CL, Illei GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB: Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum. 2000, 43: 1244-1256. 10.1002/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2.CrossRefPubMed
15.
go back to reference Pene J, Chevalier S, Preisser L, Venereau E, Guilleux MH, Ghannam S, Moles JP, Danger Y, Ravon E, Lesaux S, Yssel H, Gascan H: Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol. 2008, 180: 7423-7430.CrossRefPubMed Pene J, Chevalier S, Preisser L, Venereau E, Guilleux MH, Ghannam S, Moles JP, Danger Y, Ravon E, Lesaux S, Yssel H, Gascan H: Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol. 2008, 180: 7423-7430.CrossRefPubMed
16.
go back to reference van Kuijk AW, Reinders-Blankert P, Smeets TJ, Dijkmans BA, Tak PP: Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis. 2006, 65: 1551-1557. 10.1136/ard.2005.050963.PubMedCentralCrossRefPubMed van Kuijk AW, Reinders-Blankert P, Smeets TJ, Dijkmans BA, Tak PP: Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis. 2006, 65: 1551-1557. 10.1136/ard.2005.050963.PubMedCentralCrossRefPubMed
17.
go back to reference Canete JD, Santiago B, Cantaert T, Sanmarti R, Palacin A, Celis R, Graell E, Gil-Torregrosa B, Baeten D, Pablos JL: Ectopic lymphoid neogenesis in psoriatic arthritis. Ann Rheum Dis. 2007, 66: 720-726. 10.1136/ard.2006.062042.PubMedCentralCrossRefPubMed Canete JD, Santiago B, Cantaert T, Sanmarti R, Palacin A, Celis R, Graell E, Gil-Torregrosa B, Baeten D, Pablos JL: Ectopic lymphoid neogenesis in psoriatic arthritis. Ann Rheum Dis. 2007, 66: 720-726. 10.1136/ard.2006.062042.PubMedCentralCrossRefPubMed
18.
go back to reference Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF, Veale DJ: Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol. 2003, 30: 260-268.PubMed Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF, Veale DJ: Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol. 2003, 30: 260-268.PubMed
19.
go back to reference Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM: Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest. 2003, 111: 821-831.PubMedCentralCrossRefPubMed Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM: Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest. 2003, 111: 821-831.PubMedCentralCrossRefPubMed
20.
go back to reference Vandooren B, Cantaert T, Noordenbos T, Tak PP, Baeten D: The abundant synovial expression of the RANK/RANKL/osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. Arthritis Rheum. 2008, 58: 718-729. 10.1002/art.23290.CrossRefPubMed Vandooren B, Cantaert T, Noordenbos T, Tak PP, Baeten D: The abundant synovial expression of the RANK/RANKL/osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. Arthritis Rheum. 2008, 58: 718-729. 10.1002/art.23290.CrossRefPubMed
21.
go back to reference Viguier M, Richette P, Aubin F, Beylot-Barry M, Lahfa M, Bedane C, Delesalle F, Richard-Lallemand MA, Delaporte E, Dubertret L, Bardin T, Bachelez H: Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis. Arthritis Rheum. 2008, 58: 1796-1802. 10.1002/art.23507.CrossRefPubMed Viguier M, Richette P, Aubin F, Beylot-Barry M, Lahfa M, Bedane C, Delesalle F, Richard-Lallemand MA, Delaporte E, Dubertret L, Bardin T, Bachelez H: Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis. Arthritis Rheum. 2008, 58: 1796-1802. 10.1002/art.23507.CrossRefPubMed
22.
go back to reference Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006, 54: 2665-2673. 10.1002/art.21972.CrossRefPubMed Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006, 54: 2665-2673. 10.1002/art.21972.CrossRefPubMed
23.
go back to reference Kane D, Stafford L, Bresnihan B, FitzGerald O: A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford). 2003, 42: 1460-1468. 10.1093/rheumatology/keg384.CrossRef Kane D, Stafford L, Bresnihan B, FitzGerald O: A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford). 2003, 42: 1460-1468. 10.1093/rheumatology/keg384.CrossRef
24.
go back to reference Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL: The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum. 2001, 44: 2009-2017. 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L.CrossRefPubMed Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL: The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum. 2001, 44: 2009-2017. 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L.CrossRefPubMed
25.
go back to reference Gladman DD, Mease PJ, Ritchlin CT, Choy EH, Sharp JT, Ory PA, Perdok RJ, Sasso EH: Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial. Arthritis Rheum. 2007, 56: 476-488. 10.1002/art.22379.CrossRefPubMed Gladman DD, Mease PJ, Ritchlin CT, Choy EH, Sharp JT, Ory PA, Perdok RJ, Sasso EH: Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial. Arthritis Rheum. 2007, 56: 476-488. 10.1002/art.22379.CrossRefPubMed
26.
go back to reference Mease PJ, Kivitz AJ, Burch FX, Siegel EL, Cohen SB, Ory P, Salonen D, Rubenstein J, Sharp JT, Tsuji W: Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum. 2004, 50: 2264-2272. 10.1002/art.20335.CrossRefPubMed Mease PJ, Kivitz AJ, Burch FX, Siegel EL, Cohen SB, Ory P, Salonen D, Rubenstein J, Sharp JT, Tsuji W: Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum. 2004, 50: 2264-2272. 10.1002/art.20335.CrossRefPubMed
27.
go back to reference Ng CT, Gibbs A, Murray BF, Brady JJ, Bresnihan B, Veale DJ, McKenna MJ, FitzGerald O: Bone biomarkers and bone density measurements in patients with inflammatory arthritis prior to and following anti-TNF therapy. Ann Rheum Dis. 2008, 67 (Suppl II): 525- Ng CT, Gibbs A, Murray BF, Brady JJ, Bresnihan B, Veale DJ, McKenna MJ, FitzGerald O: Bone biomarkers and bone density measurements in patients with inflammatory arthritis prior to and following anti-TNF therapy. Ann Rheum Dis. 2008, 67 (Suppl II): 525-
28.
go back to reference Wiell C, Szkudlarek M, Hasselquist M, Moller JM, Vestergaard A, Norregaard J, Terslev L, Ostergaard M: Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis. Arthritis Res Ther. 2007, 9: R119-10.1186/ar2327.PubMedCentralCrossRefPubMed Wiell C, Szkudlarek M, Hasselquist M, Moller JM, Vestergaard A, Norregaard J, Terslev L, Ostergaard M: Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis. Arthritis Res Ther. 2007, 9: R119-10.1186/ar2327.PubMedCentralCrossRefPubMed
29.
go back to reference Balint PV, Kane D, Wilson H, McInnes IB, Sturrock RD: Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis. 2002, 61: 905-910. 10.1136/ard.61.10.905.PubMedCentralCrossRefPubMed Balint PV, Kane D, Wilson H, McInnes IB, Sturrock RD: Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis. 2002, 61: 905-910. 10.1136/ard.61.10.905.PubMedCentralCrossRefPubMed
30.
go back to reference Kane D, Greaney T, Bresnihan B, Gibney R, FitzGerald O: Ultrasonography in the diagnosis and management of psoriatic dactylitis. J Rheumatol. 1999, 26: 1746-1751.PubMed Kane D, Greaney T, Bresnihan B, Gibney R, FitzGerald O: Ultrasonography in the diagnosis and management of psoriatic dactylitis. J Rheumatol. 1999, 26: 1746-1751.PubMed
31.
go back to reference McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Emery P: Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum. 1998, 41: 694-700. 10.1002/1529-0131(199804)41:4<694::AID-ART17>3.0.CO;2-#.CrossRefPubMed McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Emery P: Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum. 1998, 41: 694-700. 10.1002/1529-0131(199804)41:4<694::AID-ART17>3.0.CO;2-#.CrossRefPubMed
32.
go back to reference McGonagle D, Conaghan PG, Emery P: Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum. 1999, 42: 1080-1086. 10.1002/1529-0131(199906)42:6<1080::AID-ANR2>3.0.CO;2-7.CrossRefPubMed McGonagle D, Conaghan PG, Emery P: Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum. 1999, 42: 1080-1086. 10.1002/1529-0131(199906)42:6<1080::AID-ANR2>3.0.CO;2-7.CrossRefPubMed
33.
go back to reference Tan AL, Benjamin M, Toumi H, Grainger AJ, Tanner SF, Emery P, McGonagle D: The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis: a high-resolution MRI and histological study. Rheumatology (Oxford). 2007, 46: 253-256. 10.1093/rheumatology/kel214.CrossRef Tan AL, Benjamin M, Toumi H, Grainger AJ, Tanner SF, Emery P, McGonagle D: The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis: a high-resolution MRI and histological study. Rheumatology (Oxford). 2007, 46: 253-256. 10.1093/rheumatology/kel214.CrossRef
34.
go back to reference Healy PJ, Groves C, Chandramohan M, Helliwell PS: MRI changes in psoriatic dactylitis: extent of pathology, relationship to tenderness and correlation with clinical indices. Rheumatology (Oxford). 2008, 47: 92-95. 10.1093/rheumatology/kem315.CrossRef Healy PJ, Groves C, Chandramohan M, Helliwell PS: MRI changes in psoriatic dactylitis: extent of pathology, relationship to tenderness and correlation with clinical indices. Rheumatology (Oxford). 2008, 47: 92-95. 10.1093/rheumatology/kem315.CrossRef
36.
go back to reference Kary S, Worm M, Audring H, Huscher D, Renelt M, Sorensen H, Stander E, Maass U, Lee H, Sterry W, Burmester GR: New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. Ann Rheum Dis. 2006, 65: 405-407. 10.1136/ard.2005.037424.PubMedCentralCrossRefPubMed Kary S, Worm M, Audring H, Huscher D, Renelt M, Sorensen H, Stander E, Maass U, Lee H, Sterry W, Burmester GR: New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. Ann Rheum Dis. 2006, 65: 405-407. 10.1136/ard.2005.037424.PubMedCentralCrossRefPubMed
37.
go back to reference Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A: Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum. 2005, 52: 2513-2518. 10.1002/art.21233.CrossRefPubMed Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A: Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum. 2005, 52: 2513-2518. 10.1002/art.21233.CrossRefPubMed
Metadata
Title
Psoriatic arthritis: from pathogenesis to therapy
Authors
Oliver FitzGerald
Robert Winchester
Publication date
01-02-2009
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2009
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2580

Other articles of this Issue 1/2009

Arthritis Research & Therapy 1/2009 Go to the issue